Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1982 1
1985 5
1986 2
1987 7
1988 1
1989 1
1990 3
1991 9
1992 12
1993 10
1994 8
1995 14
1996 15
1997 15
1998 23
1999 28
2000 37
2001 27
2002 36
2003 51
2004 63
2005 59
2006 78
2007 95
2008 125
2009 156
2010 188
2011 220
2012 234
2013 295
2014 336
2015 383
2016 410
2017 460
2018 517
2019 615
2020 746
2021 838
2022 447
2023 1
Text availability
Article attribute
Article type
Publication date

Search Results

5,897 results
Results by year
Filters applied: . Clear all
Page 1
MIR503HG Loss Promotes Endothelial-to-Mesenchymal Transition in Vascular Disease.
Monteiro JP, Rodor J, Caudrillier A, Scanlon JP, Spiroski AM, Dudnakova T, Pflüger-Müller B, Shmakova A, von Kriegsheim A, Deng L, Taylor RS, Wilson-Kanamori JR, Chen SH, Stewart K, Thomson A, Mitić T, McClure JD, Iynikkel J, Hadoke PWF, Denby L, Bradshaw AC, Caruso P, Morrell NW, Kovacic JC, Ulitsky I, Henderson NC, Caporali A, Leisegang MS, Brandes RP, Baker AH. Monteiro JP, et al. Among authors: deng l. Circ Res. 2021 Apr 16;128(8):1173-1190. doi: 10.1161/CIRCRESAHA.120.318124. Epub 2021 Mar 11. Circ Res. 2021. PMID: 33703914 Free PMC article.
Mesenchymal stem cell treatment improves outcome of COVID-19 patients via multiple immunomodulatory mechanisms.
Zhu R, Yan T, Feng Y, Liu Y, Cao H, Peng G, Yang Y, Xu Z, Liu J, Hou W, Wang X, Li Z, Deng L, Wang S, Li J, Han Q, Li H, Shan G, Cao Y, An X, Yan J, Zhang Z, Li H, Qu X, Zhu J, Zhou S, Wang J, Zhang F, Gao J, Jin R, Xu D, Ma YQ, Huang T, Peng S, Zheng Z, Stambler I, Gilson E, Lim LW, Moskalev A, Cano A, Chakrabarti S, Ulfhake B, Su H, Xu H, Xu S, Wei F, Brown-Borg HM, Min KJ, Ellison-Hughes G, Caruso C, Jin K, Zhao RC. Zhu R, et al. Among authors: deng l. Cell Res. 2021 Dec;31(12):1244-1262. doi: 10.1038/s41422-021-00573-y. Epub 2021 Oct 26. Cell Res. 2021. PMID: 34702946 Free PMC article.
Neuron-derived neuropeptide Y fine-tunes the splenic immune responses.
Yu J, Xiao K, Chen X, Deng L, Zhang L, Li Y, Gao A, Gao J, Wu C, Yang X, Zhou Q, Yang J, Bao C, Jiao J, Cheng S, Guo Z, Xu W, Cao X, Guo Z, Dai J, Hu J, Fu Z, Cao G. Yu J, et al. Among authors: deng l. Neuron. 2022 Apr 20;110(8):1327-1339.e6. doi: 10.1016/j.neuron.2022.01.010. Epub 2022 Feb 8. Neuron. 2022. PMID: 35139365
Toripalimab plus chemotherapy as second-line treatment in previously EGFR-TKI treated patients with EGFR-mutant-advanced NSCLC: a multicenter phase-II trial.
Jiang T, Wang P, Zhang J, Zhao Y, Zhou J, Fan Y, Shu Y, Liu X, Zhang H, He J, Gao G, Mu X, Bao Z, Xu Y, Guo R, Wang H, Deng L, Ma N, Zhang Y, Feng H, Yao S, Wu J, Chen L, Zhou C, Ren S. Jiang T, et al. Among authors: deng l. Signal Transduct Target Ther. 2021 Oct 15;6(1):355. doi: 10.1038/s41392-021-00751-9. Signal Transduct Target Ther. 2021. PMID: 34650034 Free PMC article. Clinical Trial.
SARS-CoV-2 Variants, South Sudan, January-March 2021.
Bugembe DL, Phan MVT, Abias AG, Ayei J, Deng LL, Lako RLL, Rumunu J, Kaleebu P, Wamala JF, Hm JJ, Lodiongo DK, Bunga S, Cotten M. Bugembe DL, et al. Among authors: deng ll. Emerg Infect Dis. 2021 Dec;27(12):3133-3136. doi: 10.3201/eid2712.211488. Epub 2021 Oct 28. Emerg Infect Dis. 2021. PMID: 34708685 Free PMC article.
5,897 results